2013 1H: Results note

Viernes, 26 Julio 2013.

Natraceutical closed the first half of the year with a net profit of 2.38 M€ compared with losses of 8.82 M€ in June 2012

  • Turnover stood at 18.16 M€, a growth of 7.7% over the first half of 2012.
  • Forté Pharma’s gradual recovery in sales together with the operational optimization conducted in the last two years led Natraceutical’s EBITDA up to 2.51 M€, compared to 1.08 M€ in the first half of 2012. EBITDA margin more than doubled from 6.4% to 13.8%.
  • The cancellation of the syndicated loan in December 2012 allowed the company to reduce the net figure between financial expenses and income from negative 2.31 M€ in the first half of 2012 to positive 0.09 M€ in the same period of 2013.

Download original text (PDF)

Esta web utiliza exclusivamente cookies técnicas de terceros para ofrecer un mejor servicio, al navegar por esta web aceptas su uso. Consulta nuestraaviso legal y política de cookies. Aceptar

DMC Firewall is developed by Dean Marshall Consultancy Ltd